Pancreatic Cancer Research

ResearcherLeiden University Medical CenterActive in the last 2 years

Anne Margarethe Stiggelbout

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6293-4509; OpenAlex author ID A5060405297. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 2 papers

Papers 4

  1. The value of FOLFIRINOX in advanced pancreatic cancer: balancing efficacy, toxicity, and quality of life. Co-author DOI 10.1007/s00520-026-10568-3↗
  2. Surgical outcomes from nationwide implementation of the international best practice for locally advanced pancreatic cancer (PREOPANC-4) study. Co-author DOI 10.1093/bjs/znag075↗
  3. Nationwide implementation of the international multidisciplinary best-practice for locally advanced pancreatic cancer (PREOPANC-4): study protocol. Co-author DOI 10.1186/s12885-025-13554-w↗
  4. The bigger picture of shared decision making: A service design perspective using the care path of locally advanced pancreatic cancer as a case. Last author DOI 10.1002/cam4.4145↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Marjolein Y.V. Homs · 2 shared papers, 2021–2026 · strength 0.44
  2. Casper H.J. van Eijck · 2 shared papers, 2021–2026 · strength 0.44
  3. Casper W.F. van Eijck · 1 shared paper, 2026 · strength 0.29
  4. Johanna W. Wilmink · 1 shared paper, 2026 · strength 0.29
  5. Judith de Vos‐Geelen · 1 shared paper, 2026 · strength 0.29
  6. Brigitte C.M. Haberkorn · 1 shared paper, 2026 · strength 0.29
  7. Aniek E. van Diepen · 1 shared paper, 2026 · strength 0.29
  8. Gaby J. Strijk · 1 shared paper, 2026 · strength 0.29
  9. Ingeborg P. M. Griffioen · 1 shared paper, 2021 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.